Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinyang Du

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Thoracic Cancer|March 29, 2022
Establishment of prognostic nomograms for predicting the progression free survival of EGFR-sensitizing mutation, advanced lung cancer patients treated with EGFR-TKIsXinyang Du, Hua Bai, Zhijie Wang, et al.
ACS Biomaterials Science & Engineering|September 25, 2025
Advanced 3D Bioprinting Technology for Cartilage Engineering and RegenerationXinyang Du, Hongyi Gu, Xinyi Ouyang, et al.
Molecular Biomedicine|October 30, 2025
Distinct survival, optimal combination strategy of immunotherapy, and immunophenotype in uncommon and 20ins EGFR-mut lung adenocarcinoma: a multi-center studyYiting Sun, Lei Xu, Chaoqiang Deng, et al.
Frontiers in Pharmacology|April 24, 2024
Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancerXiaojuan Zhang, Mina Zhang, Xinyang Du, et al.
Biomimetics (Basel, Switzerland)|October 25, 2024
Evolving the Whale Optimization Algorithm: The Development and Analysis of MISWOAChunfang Li, Yuqi Yao, Mingyi Jiang, et al.
ACS Infectious Diseases|December 21, 2023
Unveiling Synergistic Potency: Exploring Butyrolactone I to Enhance Gentamicin Efficacy against Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Strain USA300Hanxiang Jiang, Jiaqin Chen, Xinyang Du, et al.
BMC Medicine|October 7, 2021
Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLCYiting Sun, Jianchun Duan, Wenfeng Fang, et al.
Thoracic Cancer|September 20, 2022
Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancerGeyun Chang, Weihua Li, Hua Bai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2021
Efficacy and Safety of First-Line Immunotherapy Combinations for Advanced NSCLC: A Systematic Review and Network Meta-AnalysisLihui Liu, Hua Bai, Chao Wang, et al.
JAMA Network Open|October 5, 2020
Safety, Antitumor Activity, and Pharmacokinetics of Toripalimab, a Programmed Cell Death 1 Inhibitor, in Patients With Advanced Non-Small Cell Lung Cancer: A Phase 1 TrialZhijie Wang, Jianming Ying, Jiachen Xu, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Thoracic Cancer|March 29, 2022
Establishment of prognostic nomograms for predicting the progression free survival of EGFR-sensitizing mutation, advanced lung cancer patients treated with EGFR-TKIsXinyang Du, Hua Bai, Zhijie Wang, et al.
ACS Biomaterials Science & Engineering|September 25, 2025
Advanced 3D Bioprinting Technology for Cartilage Engineering and RegenerationXinyang Du, Hongyi Gu, Xinyi Ouyang, et al.
Molecular Biomedicine|October 30, 2025
Distinct survival, optimal combination strategy of immunotherapy, and immunophenotype in uncommon and 20ins EGFR-mut lung adenocarcinoma: a multi-center studyYiting Sun, Lei Xu, Chaoqiang Deng, et al.
Frontiers in Pharmacology|April 24, 2024
Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancerXiaojuan Zhang, Mina Zhang, Xinyang Du, et al.
Biomimetics (Basel, Switzerland)|October 25, 2024
Evolving the Whale Optimization Algorithm: The Development and Analysis of MISWOAChunfang Li, Yuqi Yao, Mingyi Jiang, et al.
ACS Infectious Diseases|December 21, 2023
Unveiling Synergistic Potency: Exploring Butyrolactone I to Enhance Gentamicin Efficacy against Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Strain USA300Hanxiang Jiang, Jiaqin Chen, Xinyang Du, et al.
BMC Medicine|October 7, 2021
Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLCYiting Sun, Jianchun Duan, Wenfeng Fang, et al.
Thoracic Cancer|September 20, 2022
Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancerGeyun Chang, Weihua Li, Hua Bai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2021
Efficacy and Safety of First-Line Immunotherapy Combinations for Advanced NSCLC: A Systematic Review and Network Meta-AnalysisLihui Liu, Hua Bai, Chao Wang, et al.
JAMA Network Open|October 5, 2020
Safety, Antitumor Activity, and Pharmacokinetics of Toripalimab, a Programmed Cell Death 1 Inhibitor, in Patients With Advanced Non-Small Cell Lung Cancer: A Phase 1 TrialZhijie Wang, Jianming Ying, Jiachen Xu, et al.
Pageof 2